Resources

November 2023

The EIC fund materializes its support to Epigene Labs to accelerate precision oncology R&D

This investment heralds outstanding technological and scientific strides made by Epigene Labs, which also received a multimillion grant last year as part of the EIC Accelerator program.

News

April 2023

Epigene Labs unveils open-source bioinformatics tool at AACR 2022

Publications

December 2022

The Eyquem’s group at UCSF and Epigene Labs presents early-results on CAR-T target discovery for multiple myeloma at ASH 2022

It seems we can’t find what you’re looking for.
It seems we can’t find what you’re looking for.

April 2023

Epigene Labs unveils open-source bioinformatics tool at AACR 2022

Introducing InMoose, an integrated open source Python package for multi-omic analyses

December 2022

The Eyquem’s group at UCSF and Epigene Labs presents early-results on CAR-T target discovery for multiple myeloma at ASH 2022

Integrating Transcriptomics and Proteomics for the Discovery of Novel Antigen Targets on Surface of Malignant Plasma Cells Amenable for Chimeric Antigen Receptor-T (CAR-T) Cell Approach in the Treatment of Patients with Relapsed/Refractory Multiple Myeloma
It seems we can’t find what you’re looking for.

November 2023

The EIC fund materializes its support to Epigene Labs to accelerate precision oncology R&D

This investment heralds outstanding technological and scientific strides made by Epigene Labs, which also received a multimillion grant last year as part of the EIC Accelerator program.